Annual Retained Earnings
-$227.46 M
-$10.01 M-4.60%
31 December 2023
Summary:
Akari Therapeutics annual retained earnings is currently -$227.46 million, with the most recent change of -$10.01 million (-4.60%) on 31 December 2023. During the last 3 years, it has fallen by -$45.18 million (-24.79%). AKTX annual retained earnings is now -1881.52% below its all-time high of -$11.48 million, reached on 31 December 2014.AKTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$243.48 M
-$2.90 M-1.20%
01 September 2024
Summary:
Akari Therapeutics quarterly retained earnings is currently -$243.48 million, with the most recent change of -$2.90 million (-1.20%) on 01 September 2024. AKTX quarterly retained earnings is now -2021.07% below its all-time high of -$11.48 million, reached on 31 December 2014.AKTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.6% | - |
| 3 y3 years | -24.8% | -25.6% |
| 5 y5 years | -79.4% | -79.0% |
AKTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.8% | at low | -25.6% | at low |
| 5 y | 5 years | -79.4% | at low | -79.0% | at low |
| alltime | all time | -1881.5% | at low | -2021.1% | at low |
Akari Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$243.48 M(+1.2%) |
| June 2024 | - | -$240.59 M(+3.2%) |
| Mar 2024 | - | -$233.03 M(+2.4%) |
| Dec 2023 | -$227.46 M(+4.6%) | -$227.46 M(+3.2%) |
| June 2023 | - | -$220.45 M(+4.7%) |
| Dec 2022 | -$217.45 M(+8.9%) | - |
| June 2022 | - | -$210.56 M(+2.8%) |
| Mar 2022 | - | -$204.88 M(+2.6%) |
| Dec 2021 | -$199.71 M(+9.6%) | -$199.71 M(+3.0%) |
| Sept 2021 | - | -$193.92 M(+0.8%) |
| June 2021 | - | -$192.47 M(+2.3%) |
| Mar 2021 | - | -$188.12 M(+3.2%) |
| Dec 2020 | -$182.28 M(+10.3%) | -$182.28 M(+18.2%) |
| Sept 2020 | - | -$154.17 M(-0.9%) |
| June 2020 | - | -$155.61 M(+5.6%) |
| Mar 2020 | - | -$147.29 M(-10.8%) |
| Dec 2019 | -$165.20 M(+30.3%) | -$165.20 M(+21.4%) |
| Sept 2019 | - | -$136.03 M(+1.9%) |
| June 2019 | - | -$133.47 M(+3.2%) |
| Mar 2019 | - | -$129.35 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$126.80 M(+14.9%) | -$126.80 M(+2.8%) |
| Sept 2018 | - | -$123.29 M(+3.0%) |
| June 2018 | - | -$119.70 M(+7.2%) |
| Mar 2018 | - | -$111.68 M(+1.2%) |
| Dec 2017 | -$110.34 M(+47.2%) | -$110.34 M(+12.3%) |
| Sept 2017 | - | -$98.22 M(+11.8%) |
| June 2017 | - | -$87.84 M(+0.4%) |
| Mar 2017 | - | -$87.52 M(+16.8%) |
| Dec 2016 | -$74.94 M(+31.9%) | -$74.94 M(+12.4%) |
| Sept 2016 | - | -$66.65 M(+0.6%) |
| June 2016 | - | -$66.23 M(+10.8%) |
| Mar 2016 | - | -$59.78 M(+5.3%) |
| Dec 2015 | -$56.80 M(+394.8%) | -$56.80 M(-10.2%) |
| Sept 2015 | - | -$63.27 M(+85.1%) |
| June 2015 | - | -$34.18 M(+5.1%) |
| Mar 2015 | - | -$32.51 M(+183.2%) |
| Dec 2014 | -$11.48 M(-44.1%) | -$11.48 M |
| Dec 2013 | -$20.54 M(+21.4%) | - |
| Dec 2012 | -$16.92 M(+34.1%) | - |
| Dec 2011 | -$12.62 M | - |
FAQ
- What is Akari Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Akari Therapeutics?
- What is Akari Therapeutics annual retained earnings year-on-year change?
- What is Akari Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Akari Therapeutics?
What is Akari Therapeutics annual retained earnings?
The current annual retained earnings of AKTX is -$227.46 M
What is the all time high annual retained earnings for Akari Therapeutics?
Akari Therapeutics all-time high annual retained earnings is -$11.48 M
What is Akari Therapeutics annual retained earnings year-on-year change?
Over the past year, AKTX annual retained earnings has changed by -$10.01 M (-4.60%)
What is Akari Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AKTX is -$243.48 M
What is the all time high quarterly retained earnings for Akari Therapeutics?
Akari Therapeutics all-time high quarterly retained earnings is -$11.48 M